|
|
The Commissioners below, led by Co-Chairs President Goodluck Jonathan of Nigeria and Prime Minister Jens Stoltenberg of Norway, will advocate at the highest levels to catalyze change in the way essential but under-used commodities for women’s and children’s health are produced, distributed and used. UNICEF Executive Director Anthony Lake and UNFPA Executive Director Dr. Babatunde Osotimehin will serve as Vice-Chairs of the Commission.
Michael Anderson
Director-General for Policy and Global Programmes, UK Department for International Development (DFID)
Bio forthcoming.
H. E. Zainab Hawa Bangura
Minister of Health and Sanitation, Sierra Leone
 Mrs Zainab Hawa Bangura is the Minster of Health and Sanitation of the Republic of Sierra Leone. She is the outgoing Minister of Foreign Affairs and International Cooperation, a ministry she completely overhauled, which led to the improvement of Sierra Leone’s stature in the international community. The President, Dr Ernest Bai Koroma thought it fit to move her to the Ministry of Health because health is his key priority and thought the sector could do with similar restructuring. Before becoming a government minister, Mrs Bangura was the Chief Civil Affairs Officer in the United Nations Mission in Liberia (UNMIL), heading one of UNMIL’s largest civilian components. In that position, she played a leading role in coordinating UNMIL’s participation in the restoration and consolidation of state authority in Liberia, following that country’s fourteen-year civil conflict. From 1996 to 2006, Mrs. Bangura established and led two of the Sierra Leone’s largest and most influential pro-democracy and anti-corruption NGOs – the Campaign for Good Governance and the National Accountability Group. At various stages in her career, Mrs. Bangura has worked as an Adviser and Consultant for the World Bank, UNDP and UNHCR on a variety of issues including community empowerment, inclusion and social development. She has also served as an election observer in presidential and legislative elections in Ghana, Liberia, Nigeria and Togo. Mrs Bangura has won a number of awards both in Sierra Leone and internationally. In Sierra Leone she was granted the Women of Excellence Life Achievement Award, the Alliance for Female Journalists Award, and the Expo Times Woman of the Year Award. Internationally, she has won the Democracy Courage Tributes Award of the World Movement for Democracy, the Africa International Award of Merit for Leadership, the Democracy Award of the National Endowment for Democracy, the Reagan-Fascell Democracy Fellowship, the Bayard Rustin Humanitarian Award and the Human Rights Award of the Lawyers Committee for Human Rights. In 2011, she was presented with the African American Institute’s distinguished alumna award for her role in Sierra Leone's democratic process and her contributions towards women's rights.
M. K. Bhan
Secretary to the Government of India Department of Biotechnology, Government of India
Bio forthcoming.
Heather Bresch
CEO, Mylan Inc
 Heather Bresch is chief executive officer of Mylan, one of the largest generics and specialty pharmaceutical companies in the world. She also serves on the company’s board of directors. Mylan’s mission is to provide the world’s 7 billion people access to high quality medicine. Over the course of her 20-year career at the company, Bresch has been a champion of initiatives and policy changes aimed at removing barriers that hinder patient access to high quality medicine. Some of Bresch’s key policy priorities include working to ensure that everyone living with HIV/AIDS has access to treatment; advocating for the implementation of a viable abbreviated approval pathway for safe, effective and more affordable generic versions of biologic drugs; and ensuring immediate access to critical, life-saving therapies such as Epinephrine auto-injectors – the first-line treatment for life-threatening allergic reactions, called anaphylaxis. Bresch also has been a leading advocate for ensuring one quality standard for all drugs sold in the U.S., regardless of where the product is made. She was instrumental in the development of the Generic Drug User Fee Act (GDUFA) and is strongly advocating for a needed change to the Federal Food, Drug and Cosmetic Act of 1938 (FDCA) in order to arm the U.S. Food and Drug Administration with the necessary resources and authority to regularly inspect foreign plants. Earlier in her career, Bresch played a vital role in the passage of the 2003 Medicare Modernization Act, a congressional revision to the Hatch-Waxman Act of 1984, which helped to ensure consumer access to affordable pharmaceuticals. Throughout her career with Mylan, Bresch has held roles of increasing responsibility in more than 15 functional areas. Prior to becoming CEO, Bresch served as Mylan’s president, where she was responsible for the day-to-day operations of the company. Before that, she served as Mylan’s chief operating officer and chief integration officer, leading the successful integration of two transformational and game-changing international acquisitions – Matrix Laboratories and Merck KGaA’s generics business. In addition, Bresch has served as head of Mylan’s North America operations. Bresch has served two consecutive terms as chairman of the Generic Pharmaceutical Association and one term as its vice chairman. Bresch earned her undergraduate degree from West Virginia University.
Dan Brutto
President, UPS International
 Daniel J. Brutto, 55, has served as Senior Vice President of United Parcel Service, Inc., a global package delivery, supply chain management and freight forwarding company, and President of UPS International, since January 2008. Previously he served as President, Global Freight Forwarding, for UPS from 2006 to 2007, and corporate controller from 2004 to 2006. Mr. Brutto has over 36 years of experience at UPS, serving over the years in various functional areas with increasing levels of responsibility, including operations, finance, information systems, mergers & acquisitions, marketing, business development and international. Mr. Brutto was elected as a director of ITW in February 2012 and has not served as a director of any other publicly traded company in the last five years. Mr. Brutto serves on the board of directors of UNICEF, UPS Foundation, the US-China Business Council, and he has also served on the Guangdong Economic Council and the Turkey Economic Advisory Council. He was also a delegate to the World Economic Forum, Davos, Switzerland, for 5 of the last 6 years. Mr. Brutto’s experience integrating multiple freight forwarding units and establishing UPS operations in 35 countries across Europe and Asia, as well as his global perspective, were considered valuable additions to the Board.
Ray Chambers
UN Secretary-General’s Special Envoy for Malaria
Ray Chambers is a philanthropist and humanitarian who has directed most of his efforts towards helping children. He is the founding Chairman of the Points of Light Foundation and co-founder, with Colin Powell, of America’s Promise -- The Alliance for Youth. He also co-founded the National Mentoring Partnership and the Millennium Promise Alliance. Chambers is the co-founder of Malaria No More, with Peter Chernin. He is the Founding Chairman of the New Jersey Performing Arts Center and is the former Chairman of Wesray Capital Corporation, which he co-founded with William E. Simon.
Jamie Cooper-Hohn
President and CEO, Children’s Investment Fund Foundation
 The Children’s Investment Fund Foundation (CIFF) is an independent, non-profit, philanthropic organisation formally linked to an investment fund which contributes a portion of its management fees and profits to the Foundation. Founded in 2003, CIFF aims to demonstrably improve the lives of children living in poverty in developing countries through high impact, large-scale and sustainable interventions. CIFF invests primarily in sub-Saharan Africa and India around a highly focused portfolio of programmes, targeting explicit intervention areas where the Foundation assesses it can deliver high return for children. CIFF funds partners which CIFF views as having high potential to achieve large scale, measurable outcomes and sustainable change, and who are committed to engaging with CIFF to use data to continually assess progress and adapt as necessary to increase impact. CIFF has an asset base of more than $3 billion and currently employs approximately 45 professionals in the United Kingdom, Africa and India. Jamie Cooper-Hohn is a co-founder of CIFF and serves as the Foundation's President and CEO. Jamie has more than 20 years experience in roles that have involved bringing private sector, government and non-profit leaders together to pursue innovative policy and programming around a broad array of economic and social issues. Prior to assuming leadership of the Foundation, she served as Co-Director of Shine Trust, a grant making trust supporting children in poverty in England through educational initiatives. She also served as Vice President of Strategic Planning and Development for Gould Partners in New York City, a non-profit collaborative effort aimed at expanding educational opportunities for inner city children and their families. As Associate Director for the Center for Policy Alternatives in Washington, DC, Jamie led the organisation's efforts to promote innovative legislative responses to social and economic issues. Her other experiences include working for CBS News and the Atlanta Project, an initiative of President Jimmy Carter. Jamie received a Bachelor of Arts from Smith College and a Masters in Public Administration from the John F. Kennedy School of Government at Harvard University.
Gary Cohen
Executive Vice President, Becton Dickinson (BD)
 Gary Cohen is executive vice president of BD, a global medical technology company with over $7 billion revenues and 29,000 employees in 50 countries. He serves as board chair of the CDC Foundation and a board director of the Perrigo Company, the US Fund for UNICEF, GBCHealth and the Accordia Global Health Foundation. He also serves as chair of the CDC/Corporate Roundtable on Global Health Threats, and an advisor to the Clinton Global Initiative and the Massachusetts General Hospital Center for Global Health. Gary and the BD team are extensively engaged in collaborations across the public, private and NGO sectors to address health needs in developing and emerging countries. He has served as an advocate, speaker and expert panelist on global health, child immunization, HIV/AIDS and health system strengthening, in venues including the United Nations, World Bank, World Economic Forum (Davos), US Department of State and Council on Foreign Relations. Gary founded Together for Girls, a new partnership to address the human rights and public health impacts of sexual violence against girls, comprised of five UN agencies, CDC, the US Department of State, BD and other partners. He has been honored for his humanitarian work by MESAB (Medical Education for South African Blacks), B’nai B’rith International, the US Fund for UNICEF, the Nyumbani Home for Abandoned and Orphaned HIV+ Children and the Dikembe Mutombo Foundation. He earned a BA from Rutgers College and a MBA from the Rutgers Graduate School of Management, and previously served on the university’s Board of Trustees.
Bob Collymore
Chief Executive Officer, Safaricom
 Bob is the CEO of Safaricom Limited, one of the leading integrated communications companies in Africa. He assumed the position on November 1st 2010. Prior to joining Safaricom, Bob was the Chief Officer for Corporate Affairs in Vodacom Group responsible for the Group’s Corporate Communication, Ethics and Compliance, Legal, External Relationships and Corporate Social Responsibility. Prior to that, he was Vodafone’s Governance Director for Africa where he was responsible for developing and driving Vodafone’s strategy for its investments in Africa as well as representing Vodafone as a key direct foreign investor in a number of African countries. Bob has more than 25 years of commercial experience working in the telecommunications sector. Previously, Bob spent 3 years working in Tokyo as Vodafone’s Director, Consumer Marketing (Asia), overseeing the development and alignment of Vodafone’s Japanese business. His previous roles included Global Purchasing Director for Vodafone and Purchasing Director for the Dixons Stores Group, one of the UK’s largest electrical retailers. Bob is also a trustee of Holding companies in Kenya and Tanzania for M-PESA, Vodafone’s pioneering money transfer service. Mr. Collymore has also been recognized as one of Africa’s Top 10 Telecom Leaders, based on his executive achievements and his companies’ business performance. As one of Africa’s ICT business leader, he has made great strides in building a successful African Telecommunications company and innovation has played a crucial part in its success.
Christopher Elias
President for Global Development, Bill and Melinda Gates Foundation
Bio forthcoming.
Kenneth C. Frazier
President and CEO, Merck
 Kenneth C. Frazier is chairman of the board, president and chief executive officer of Merck & Co., Inc. Previously, Ken served as president of Merck, with responsibility for the company’s three major divisions: Global Human Health, Merck’s sales and marketing division for pharmaceutical and vaccine products; Merck Manufacturing Division, Merck’s manufacturing and supply division; and Merck Research Laboratories, Merck’s research organization. Ken has held a broad range of senior management positions since joining Merck in 1992 as vice president, general counsel and secretary of the Astra Merck Group. He was elected vice president of public affairs in 1994 and in 1997 assumed the additional responsibilities of assistant general counsel, corporate staff. Ken was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In this role, he oversaw Merck’s legal and public affairs functions and The Merck Company Foundation. In November 2006, he was promoted to executive vice president and general counsel. Ken served as executive vice president and president, Global Human Health, from 2007 to May 2010, when he became Merck president. Ken became CEO and member of the board of directors January 1, 2011, and became chairman of the board on December 1, 2011. Before joining Merck, Ken was a partner with the Philadelphia law firm of Drinker Biddle & Reath. Ken sits on the boards of Exxon Mobil Corporation, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA. Ken also is a member of the Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association. Ken received his bachelor’s degree from The Pennsylvania State University and holds a J.D. from Harvard Law School.
Julio Frenk
Chair, Partnership for Maternal, Newborn and Child Health
Dean, Harvard School of Public Health
 Since January 2009, Dr. Julio Frenk is Dean of the Faculty at the Harvard School of Public Health and T & G Angelopoulos Professor of Public Health and International Development, a joint appointment between the Harvard Kennedy School of Government and HSPH. Dr. Frenk served as the Minister of Health of Mexico from 2000 to 2006, where he introduced universal health insurance. He has also held leadership positions at the National Institute of Public Health of Mexico, the Mexican Health Foundation, the World Health Organization, the Bill and Melinda Gates Foundation, and the Carso Health Institute. He is a member of the Institute of Medicine, the American Academy of Arts and Sciences, and the National Academy of Medicine of Mexico. In September of 2008, Dr. Frenk received the Clinton Global Citizen Award for changing “the way practitioners and policy makers across the world think about health.”
Desde enero de 2009, el Dr. Julio Frenk es decano de la Escuela de Salud Pública de la Universidad Harvard y Profesor T & G Angelopoulos de Salud Pública y Salud Internacional, un nombramiento conjunto de la Escuela Kennedy de Gobierno de Harvard y la Escuela de Salud Pública. El Dr. Frenk fue Secretario de Salud de México de 2000 a 2006, periodo durante el cual sentó las bases de la protección social en salud universal. Ha ocupado también cargos de liderazgo en el Instituto Nacional de Salud Pública, la Fundación Mexicana para la Salud, la Organización Mundial de la Salud, la Fundación Bill y Melinda Gates, y el Instituto Carso de la Salud. Es miembro de la Academia Nacional de Medicina de México, del Instituto de Medicina de Estados Unidos y de la Academia Americana de Artes y Ciencias. En septiembre de 2008, el Dr. Frenk recibió el Premio Clinton al Ciudadano Global por cambiar “la manera en que los prestadores de servicios y los tomadores de decisiones de todo el mundo piensan sobre la salud.”
Teguest Guerma
Director General, AMREF
 Dr Teguest Guerma is currently the Director General of AMREF, an International nongovernmental organization working in Health Development. AMREF’s vision is a lasting health change in Africa through the transformation of communities from within. Prior to that she was the Associate Director and later the acting Director of the Global HIV and AIDs Department in WHO, Geneva. Dr Guerma has over 26 years experience in public heath from which 21 years is with WHO (World Health Organization). She has an extensive experience at country, regional and global level in Africa, Asia, Europe and the US. She served as the WHO Africa representative to UN Headquarters, New York, USA, and WHO representative in Nepal and Botswana. .Dr Guerma co-led the WHO 3x5 Initiative which made Antiretroviral treatment available to developing countries. Dr Guerma started her career as a medical practitioner in Burundi in the mid-1980s and holds a medical Doctor degree with post graduate degree in Infectious Diseases and a certificate of Epidemiology. Dr Guerma is an Ethiopian National and a mother of two children.
Per Heggenes
CEO, IKEA Foundation
Bio forthcoming.
Mr. Li Dongjiu (Robert Lee)
President, Shanghai Fosun Pharmaceutical Development Co., Ltd. China
 Mr. Li Dongjiu (Robert Lee) became President of Shanghai Fosun Pharmaceutical Development Co., Ltd., Director of Pharmaceutical Industry Management Committee of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., and Senior President of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in December 2009. He is also Vice President of China Nonprescription Medicines Association (CNMA) and the China advisor for the United States Pharmacopeial Convention (USP) from 2007. Born in Gansu China, Mr. Li Dongjiu earned a Bachelor of Chemical Engineering from the Dalian University of Technology and a Masters in Management science and Engineering at Wuhan University of Technology and Master of Arts (International relations in Economy and Trade) from Flinders University of South Australia. He held a number of senior roles with North China Pharmaceutical Co., Ltd.(NCPC), where he rose to be Vice President in charge of financial ,Marketing and International Cooperation. For More than a decade he worked alongside staff at every level and helped the company develop into top 5 pharmaceutical companies in China with 20,000 employees. He has been married and has one adult child.
Hassan Mshinda
Director, General Tanzania Commission for Science and Technology
 Dr. Hassan Mshinda is the Director General of Tanzania Commission for Science and Technology in Tanzania. He completed his Master’s of Science in Applied Parasitology and Medical Technology with University of Liverpool and PhD in Epidemiology with University of Basel in Switzerland. Dr. Mshinda has led several research projects funded by WHO/TDR, Swiss Agency for Development and Cooperation, International Atomic Energy Agency, International Development Research Centre in Canada, European Union, Ireland Aid, Novartis Foundation for Sustainable Development, Comic Relief and Bill and Melinda Gates Foundation. He has published extensively on communicable diseases and health system. Some of the research findings have led into formulation of national and international policy. He was the Director of Ifakara Health Institute for more than ten years and the Institute received Prince of Astuaris Award on International Cooperation 2008. Dr Mshinda has conducted several international and national consultancies assigned by UK Department of International Development, Danish Development Agency and World Health Organisation. Global Fund for HIV/AIDS, TB and Malaria. Dr. Mshinda is the Chairperson of the Board of Ifakara Health Institute was the Member and Chairman of INDEPTH Board, INDEPTH is an international Network for the Demographic Evaluation of Populations and their Health In Developing Countries involves 43 sites in Africa and Asia. He is a Board member of several research and technology based institutions in Tanzania. Currently, He is a Commissioner for the United Nations Commission on Life-Saving Commodities for Women and Children and Honorary Professor of University of Liverpool.
Agnès Saint-Raymond
Head of Human Medicines Special Areas, European Medicines Agency (EMA)
 Dr Agnès Saint-Raymond is French and studied in Paris. She obtained her MD from Lariboisiere-St Louis University. She qualified as a Paediatrician in 1987 and worked as Chef de Clinique in Paediatrics in Necker-Enfants-Malades Hospital (Paris) with special interest in paediatric gastro-enterology, rheumatology and cystic fibrosis. She spent five years in pharmaceutical companies, then joined in 1995 the French Medicines Agency as Head of a Pharmaco-Toxico-Clinical Assessment Unit. In 2000 she joined the European Medicines Agency (EMA) in London, EU, a decentralised Agency of the European Union, working with the network of national regulatory Agencies in Europe. She is the Head of Sector for Special Areas (which includes Paediatric Medicines, Orphan Medicines, Scientific Advice, the Small & Medium-sized Enterprises Office, and Scientific Support & Projects) in the Unit for the Development and Evaluation of Human Medicines. She has been in charge of the implementation of the European Paediatric Regulation, a new legal framework of the European Union, which mandates development of medicines, including age-appropriate formulations, for children from birth to adulthood wherever there is benefit or unmet paediatric needs. She is also the Chair of the WHO network of Regulatory Agencies on Paediatric Medicines (PmRN).
Rajiv Shah
Administrator, USAID
 Dr. Rajiv Shah serves as the 16th Administrator of the United States Agency for International Development (USAID) and leads the efforts of more than 8,000 professionals in 80 missions around the world. Since being sworn in on Dec. 31, 2009, Administrator Shah managed the U.S. Government's response to the devastating 2010 earthquake in Port-au-Prince, co-chaired the State Department's first-ever review of American diplomacy and development operations, and now spearheads President Obama's landmark Feed the Future food security initiative. He is also leading “USAID Forward,” an extensive set of reforms to USAID's business model around seven key areas, including procurement, science & technology, and monitoring & evaluation. Before becoming USAID's Administrator, Dr. Shah served as Under Secretary for Research, Education and Economics and as Chief Scientist at the U.S. Department of Agriculture. At USDA, he launched the National Institute of Food and Agriculture, a new scientific institute that significantly elevates the status and funding of agricultural research. Prior to joining the Obama Administration, Shah served for seven years with the Bill and Melinda Gates Foundation where his positions included Director of Agricultural Development in the Global Development Program, and Director of Strategic Opportunities.
Jasmine Whitbread
CEO, Save the Children International
 Jasmine became the first international CEO of Save the Children in April 2010, after serving as Chief Executive of Save the Children UK from 2005. Save the Children is the world’s leading independent organisation for children, working in 120 countries with revenues of over 1.4 billion USD. Save the Children is delivering on significant commitments to EVERY WOMAN EVERY CHILD through its global campaign to stop preventable deaths of under-fives. Before joining Save the Children, Jasmine spent six years with Oxfam, first as Regional Director in West Africa, and then as International Director responsible for Oxfam's programmes worldwide. Prior to this, Jasmine was Managing Director of a Thomson Financial business, based in the US. She has a background in international marketing in the technology sector, and early in her career was a VSO volunteer with the National Union of Disabled Persons of Uganda. Jasmine graduated from the University of Bristol in 1986 and completed the Executive Program at the Graduate School of Business, Stanford, California in 1997. She holds dual British/Swiss nationality and is married with two children. Jasmine is a non-executive director of BT Group Plc. and a governor of the Dragon School.
Sir Andrew Witty
Chief Executive Officer, GlaxoSmithKline
Bio forthcoming.
|
|
